Notably, a reduction in Faecalibacterium prausnitzii has been associated with greater symptom severity, possibly due to its anti-inflammatory properties [86]
A 2023 JAMA study found that people using GLP-1 drugs had a higher risk of gastroparesis and bowel obstruction compared to those taking bupropion-naltrexone
5.1.2 Non-enzymatic antioxidants The human bodys non-enzymatic antioxidant system is made up of low-weight antioxidant compounds such as coenzyme Q10, lipoic acid, melatonin, and bilirubin, as well as antioxidant proteins (metal binding) like albumin, lactoferrin, ceruplasmin, ferritin, transferrin, and metallothioneins
The difference between GLP-1 and GLP-2 matters here
Here, too, researchers found no consistent increased risk from taking GLP-1 drugs in a 2025 analysis of data from 62 studies
a Wegovy Pill: I am not going to go into much detail on microdosing semaglutide shots